Related Experiment Video
Updated: Oct 7, 2025

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
Repurposing the Homing Endonuclease I-SceI for Positive Selection and Development of Gene-Editing Technologies
Kok Zhi Lee1, Michael A Mechikoff1, Mrugesh Krishna Parasa2,3
1Department of Agricultural and Biological Engineering, Purdue University, 225 South University Street, West Lafayette, Indiana 47907-2093, United States.
Abstract:
Prokaryote genomes encode diverse programmable DNA endonucleases with significant potential for biotechnology and gene editing. However, these endonucleases differ significantly in their properties, which must be screened and measured. While positive selection screens based on ccdB and barnase have been developed to evaluate such proteins, their high levels of toxicity make them challenging to use. Here, we develop and validate a more robust positive selection screen based on the homing endonuclease I-SceI. Candidate endonucleases target and cure the I-SceI expression plasmid preventing induction of I-SceI-mediated double strand DNA breaks that lead to cell death in E. coli. We validated this screen to measure the relative activity of SpCas9, xCas9, and eSpCas9 and demonstrated an ability to enrich for more active endonuclease variants from a mixed population. This system may be applied in high throughput to rapidly characterize novel programmable endonucleases and be adapted for directed evolution of endonuclease function.
Related Concept Videos
CRISPR/Cas9 Genome Editing
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
CRISPR
Homologous Recombination
In-vitro Mutagenesis

